Generating blood vessels with angiogenic material containing a biocompatible polymer and polymerizable compound

• US 6,261,585 B1
• Filed: 04/30/1998
• Issued: 07/17/2001
• Est. Priority Date: 10/31/1995
• Status: Expired due to Fees

• Current Assignee: Julia E. Babensee, Michael H. May, Michael Vivian Sefton
• Original Assignee: Julia E. Babensee, Michael H. May, Michael Vivian Sefton
• Inventors: Babensee, Julia E., May, Michael H., Sefton, Michael Vivian
• Primary Examiner(s): Naff, David M.
• Application Number:
  US09/069,544
• Time in Patent Office: 1,174 Days
• Field of Search: 435/174, 435/177, 435/180, 435/182, 435/382, 435/395, 424/422, 424/423, 424/489, 424/501, 424/93.7
• US Class Current: 424/423
• CPC Class Codes: A61K 9/5089 Processes

Abstract

An angiogenic material is provided which promotes extensive vascularization when implanted in animal tissue. The angiogenic material contains a biocompatible polymer and a vascularizing polymerizable compound capable of forming anions. The polymer may be a polyacrylate, and the polymerizable compound includes compounds having ionizable groups selected from sulfates, sulfonic acid groups and carboxyl groups. These compounds include acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid and vinylacetic acid. The angiogenic material is preferably used in microcapsule coatings and microspheres for implantation in animals. In microcapsules, the angiogenic material promotes better exchange of nutrients, waste products and cellular products between encapsulated cells and the circulatory system of the host animal. Microspheres containing the angiogenic material may be used to assist in recovery of ischemic heart muscle by injection of the microspheres into the heart muscle or blood vessels serving the ischemic area. Also provided is a method of forming small microcapsules and microspheres by passing cell aggregates or air bubbles through layers of a density gradient to obtain microcapsules or microspheres having a diameter no greater than 500 μm that contain cells or do not contain cells. When cells are present, a semi-permeable coating of the angiogenic material surrounds the cells.

Claims

1. A method of increasing blood flow to a ischemic animal tissue consisting of ischemic heart muscle or ischemic peripheral tissue comprising implanting an angiogenic material into the ischemic animal tissue or blood vessels in the immediate vicinity of the ischemic animal tissue,

said angiogenic material consisting of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions and which promote the growth of blood vessels, which, when implanted in said animal tissue, said angiogenic material promotes generation of blood vessels in its immediate vicinity and induces minimal or no fibrous capsule formation.

2. A method as claimed in claim 1, wherein said vascularization compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

3. A method as claimed in claim 1, wherein said vascularization compound consists of acrylic acid, methacrylic acid, crotonic acid, itaconic acid, vinylsulfonic acid or vinylacetic acid.

4. A method as claimed in claim 1, wherein said biocompatible polymer consists of polyacrylates.

5. A method as claimed in claim 1, wherein said vascularization compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.

6. A method of increasing blood flow to ischemic animal tissue consisting of ischemic heart muscle or ischemic peripheral tissue comprising implanting microspheres consisting of an angiogenic material into the ischemic animal tissue or blood vessels in the immediate vicinity of the ischemic animal tissue,

said microspheres having a diameter of no greater than 500 μ

m,

said angiogenic material consisting of a biocompatible polymer and a vascularizing compound consisting of polymerizable compounds capable of forming anions and which promote the growth of blood vessels, which, when implanted in said animal tissue, said angiogenic material promotes generation of blood vessels in its immediate vicinity and induces minimal or no fibrous capsule formation.

7. A method as claimed in claim 6, wherein said vascularization compound consists of a polymerizable compound containing an ionizable group consisting of sulfates, sulfonic acid groups or carboxyl groups.

8. A method as claimed in claim 6, wherein said vascularization compound consists of acrylic acid, methacrylic acid, crotonic acid, Itaconic acid, vinylsulfonic acid or vinylacetic acid.

9. A method as claimed in claim 6, wherein said biocompatible polymer consists of polyacrylates.

10. A method as claimed in claim 6, wherein said vascularization compound consists of methacrylic acid which is incorporated into the biocompatible polymer at the time of polymerization.

11. A method as claimed in claim 6 wherein said microspheres have a diameter of less than 200 μ

m.

12. A method as claimed in claim 6 wherein said microspheres have a diameter of from about 10 μ

m to about 50 μ

m.